CDNA
Price
$27.10
Change
-$0.03 (-0.11%)
Updated
Sep 6 closing price
54 days until earnings call
NAOV
Price
$0.59
Change
+$0.05 (+9.26%)
Updated
Sep 6 closing price
Ad is loading...

CDNA vs NAOV

Header iconCDNA vs NAOV Comparison
Open Charts CDNA vs NAOVBanner chart's image
CareDx
Price$27.10
Change-$0.03 (-0.11%)
Volume$654.78K
CapitalizationN/A
NanoVibronix
Price$0.59
Change+$0.05 (+9.26%)
Volume$18.59K
CapitalizationN/A
View a ticker or compare two or three
CDNA vs NAOV Comparison Chart
Loading...
CDNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NAOV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CDNA vs. NAOV commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDNA is a Hold and NAOV is a StrongBuy.

COMPARISON
Comparison
Sep 08, 2024
Stock price -- (CDNA: $27.13 vs. NAOV: $0.54)
Brand notoriety: CDNA and NAOV are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CDNA: 101% vs. NAOV: 74%
Market capitalization -- CDNA: $548.33M vs. NAOV: $1.8M
CDNA [@Medical Specialties] is valued at $548.33M. NAOV’s [@Medical Specialties] market capitalization is $1.8M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDNA’s FA Score shows that 1 FA rating(s) are green whileNAOV’s FA Score has 1 green FA rating(s).

  • CDNA’s FA Score: 1 green, 4 red.
  • NAOV’s FA Score: 1 green, 4 red.
According to our system of comparison, CDNA is a better buy in the long-term than NAOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDNA’s TA Score shows that 4 TA indicator(s) are bullish while NAOV’s TA Score has 5 bullish TA indicator(s).

  • CDNA’s TA Score: 4 bullish, 4 bearish.
  • NAOV’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, NAOV is a better buy in the short-term than CDNA.

Price Growth

CDNA (@Medical Specialties) experienced а -12.23% price change this week, while NAOV (@Medical Specialties) price change was -5.54% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.45%. For the same industry, the average monthly price growth was +4.17%, and the average quarterly price growth was -7.83%.

Reported Earning Dates

CDNA is expected to report earnings on Oct 31, 2024.

NAOV is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Medical Specialties (-1.45% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDNA($548M) has a higher market cap than NAOV($1.8M). CDNA YTD gains are higher at: 126.083 vs. NAOV (-52.870). NAOV has higher annual earnings (EBITDA): -4.49M vs. CDNA (-84.92M). CDNA has more cash in the bank: 235M vs. NAOV (3.79M). NAOV has less debt than CDNA: NAOV (19K) vs CDNA (34.2M). CDNA has higher revenues than NAOV: CDNA (280M) vs NAOV (1M).
CDNANAOVCDNA / NAOV
Capitalization548M1.8M30,428%
EBITDA-84.92M-4.49M1,890%
Gain YTD126.083-52.870-238%
P/E RatioN/AN/A-
Revenue280M1M27,888%
Total Cash235M3.79M6,205%
Total Debt34.2M19K180,000%
FUNDAMENTALS RATINGS
CDNA vs NAOV: Fundamental Ratings
CDNA
NAOV
OUTLOOK RATING
1..100
6867
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
3489
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAOV's Valuation (29) in the Medical Specialties industry is significantly better than the same rating for CDNA (100). This means that NAOV’s stock grew significantly faster than CDNA’s over the last 12 months.

CDNA's Profit vs Risk Rating (95) in the Medical Specialties industry is in the same range as NAOV (100). This means that CDNA’s stock grew similarly to NAOV’s over the last 12 months.

CDNA's SMR Rating (97) in the Medical Specialties industry is in the same range as NAOV (99). This means that CDNA’s stock grew similarly to NAOV’s over the last 12 months.

CDNA's Price Growth Rating (34) in the Medical Specialties industry is somewhat better than the same rating for NAOV (89). This means that CDNA’s stock grew somewhat faster than NAOV’s over the last 12 months.

CDNA's P/E Growth Rating (1) in the Medical Specialties industry is significantly better than the same rating for NAOV (100). This means that CDNA’s stock grew significantly faster than NAOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDNANAOV
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
CDNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NAOV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SICNX12.37N/A
N/A
Schwab® International Core Equity
DNMDX28.40-0.01
-0.04%
Dunham Monthly Distribution N
IYGIX37.96-0.02
-0.05%
Delaware Ivy Large Cap Growth Fund I
MSURX9.27-0.03
-0.32%
Morgan Stanley Inst US Real Estate C
GTSGX16.87-0.08
-0.47%
Madison Mid Cap Y

CDNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDNA has been loosely correlated with NTRA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CDNA jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDNA
1D Price
Change %
CDNA100%
-1.99%
NTRA - CDNA
48%
Loosely correlated
+3.76%
VCYT - CDNA
46%
Loosely correlated
+0.76%
MTD - CDNA
45%
Loosely correlated
-0.08%
LH - CDNA
45%
Loosely correlated
-0.32%
WAT - CDNA
43%
Loosely correlated
-0.08%
More

NAOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAOV has been loosely correlated with CLPT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NAOV jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAOV
1D Price
Change %
NAOV100%
-5.16%
CLPT - NAOV
33%
Loosely correlated
-0.56%
TTOO - NAOV
33%
Loosely correlated
+6.19%
CDNA - NAOV
31%
Poorly correlated
-1.99%
SENS - NAOV
31%
Poorly correlated
-4.04%
NARI - NAOV
30%
Poorly correlated
-3.23%
More